HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

solanezumab

a humanized anti-beta-amyloid monoclonal antibody
Also Known As:
LY 2062430; LY-2062430; LY2062430
Networked: 67 relevant articles (3 outcomes, 48 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Siemers, Eric: 10 articles (01/2022 - 07/2011)
2. Dean, Robert A: 9 articles (01/2018 - 03/2010)
3. Liu-Seifert, Hong: 8 articles (01/2018 - 01/2014)
4. Siemers, Eric R: 7 articles (01/2019 - 03/2010)
5. Imbimbo, Bruno P: 6 articles (02/2021 - 02/2012)
6. Case, Michael: 5 articles (01/2022 - 01/2016)
7. Holdridge, Karen C: 5 articles (01/2022 - 01/2015)
8. Carlson, Christopher: 5 articles (01/2018 - 07/2011)
9. Panza, Francesco: 5 articles (01/2018 - 02/2012)
10. Solfrizzi, Vincenzo: 5 articles (01/2018 - 02/2012)

Related Diseases

1. Alzheimer Disease (Alzheimer's Disease)
2. Cognitive Dysfunction
3. Dementia (Dementias)
4. Amyloid Plaque
5. Disease Progression

Related Drugs and Biologics

1. Amyloid (Amyloid Fibrils)
2. gantenerumab
3. crenezumab
4. Biomarkers (Surrogate Marker)
5. Antibodies
6. aducanumab
7. APT
8. Vaccines
9. bapineuzumab
10. Monoclonal Antibodies

Related Therapies and Procedures

1. Immunotherapy
2. Activities of Daily Living (ADL)
3. Intravenous Infusions
4. Aftercare (After-Treatment)